Capital Bank & Trust CO Illumina, Inc. Transaction History

Capital Bank & Trust CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $278,884 - $360,162	-748 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$268.51 - $400.74 $200,845 - $299,753	748 New	748 $231,000
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $64,371 - $93,625	-251 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$209.2 - $335.53 $3,347 - $5,368	-16 Reduced 5.99%	251 $69,000
Q4 2019 Feb 18, 2020	SELL	$288.29 - $335.49 $8,648 - $10,064	-30 Reduced 10.1%	267 $89,000
Q3 2019 Nov 14, 2019	SELL	$266.84 - $378.23 $34,422 - $48,791	-129 Reduced 30.28%	297 $90,000
Q2 2019 Aug 14, 2019	BUY	$300.59 - $368.15 $88,974 - $108,972	296 Added 227.69%	426 $157,000
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $16,899 - $19,913	-62 Reduced 32.29%	130 $40,000
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $52,180 - $68,640	187 Added 3740.0%	192 $70,000
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $1,011 - $1,150	5 New	5 $1,000
Q3 2017 Nov 14, 2017	SELL	$172.3 - $213.93 $39,629 - $49,203	-230 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	230	230 $40,000

899

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.